CG
RGNX icon

Cutler Group’s Regenxbio RGNX Stock Holding History

Cutler Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,200
Closed -$23K – 4243
2023
Q2 		$23K Sell
1,200
-2,363
-66% -$45.5K ﹤0.01% 1782
2023
Q1 		$67K Buy
3,563
+2,707
+316% +$59.9K 0.01% 1179
2022
Q4 		$19K Buy
856
+636
+289% +$14.4K ﹤0.01% 2259
2022
Q3 		$5K Sell
220
-380
-63% -$11.3K ﹤0.01% 3686
2022
Q2 		$14K Buy
+600
New +$15K ﹤0.01% 2965
2021
Q4 		– Sell
-1,200
Closed -$50K – 5928
2021
Q3 		$50K Sell
1,200
-222
-16% -$7.99K ﹤0.01% 2510
2021
Q2 		$55K Buy
1,422
+1,222
+611% +$43.7K ﹤0.01% 2414
2021
Q1 		$6K Sell
200
-3,200
-94% -$136K ﹤0.01% 4263
2020
Q4 		$154K Buy
+3,400
New +$119K 0.01% 1242
2020
Q2 		– Sell
-1,800
Closed -$67.1K – 4777
2020
Q1 		$58K Buy
1,800
+600
+50% +$25K ﹤0.01% 1639
2019
Q4 		$49K Buy
1,200
+300
+33% +$11.9K ﹤0.01% 1644
2019
Q3 		$32K Sell
900
-6,400
-88% -$259K ﹤0.01% 1848
2019
Q2 		$375K Buy
7,300
+4,400
+152% +$220K 0.03% 432
2019
Q1 		$166K Sell
2,900
-1,300
-31% -$64.4K 0.02% 740
2018
Q4 		$176K Sell
4,200
-1,400
-25% -$82.1K 0.02% 707
2018
Q3 		$422K Buy
5,600
+5,233
+1,426% +$377K 0.03% 531
2018
Q2 		$26K Sell
367
-533
-59% -$25.5K ﹤0.01% 2014
2018
Q1 		$26K Sell
900
-7,357
-89% -$214K ﹤0.01% 2103
2017
Q4 		$274K Buy
8,257
+4,504
+120% +$136K 0.01% 805
2017
Q3 		$123K Buy
+3,753
New +$84.5K ﹤0.01% 1496

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Cutler Group's RGNX Position: Q3 2023 in Review

Cutler Group sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 1,200 shares — an estimated $23K sold.

Cutler Group first reported a position in RGNX in Q3 2017 and held it in 20 quarters. The position peaked at $422K in Q3 2018. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • Cutler Group reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,200 Regenxbio shares in Q3 2023, an estimated $23K.
  • Cutler Group first reported a position in Regenxbio in Q3 2017 and held it in 20 quarters.
  • Cutler Group's Regenxbio position peaked at $422K in Q3 2018.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.